RxDoctor Payments DataLook up a doctor →

Rami Mortada, MD

Endocrinology, Diabetes & Metabolism · Wichita, KSNPI 1174720205

Payments from drug & device makers

$105,366in general payments, 2019–2025

Across 1,135 payments — averaging $92.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$92K
  • Lilly USA, LLC$2K
  • Dexcom, Inc.$1K
  • Amgen$1K
  • AstraZeneca$1K
  • Abbott$873
  • plus $7K from 47 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$105,366 in reported general payments places this provider in the 85th percentile of 50 endocrinology, diabetes & metabolism providers in Kansas.

See all endocrinology, diabetes & metabolism providers in Kansas

Medicare billing

Part B allowed, 2024
$217,494
Medicare patients
844
Services billed
24,711

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →